Highlights of the Annual Meeting of the European Association of Nuclear Medicine: Copenhagen 1996. Nuclear medicine 100 years after the discovery of radioactivity

European Journal of Nuclear Medicine

Volumn 24, Issue 2, 1997, Pages 219-232

  Delaloye, Angelika Bischof ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

CARDIOLOGY; CONFERENCE PAPER; HEMATOLOGY; NEUROLOGY; NUCLEAR MEDICINE; ONCOLOGY; RADIOTHERAPY; TUMOR SCINTISCANNING;

ADULT; CHILD; EUROPE; HEART; HUMANS; INFANT; INFECTION; NEOPLASMS; NUCLEAR MEDICINE; SOCIETIES, MEDICAL;

EID: 0030968109     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439558     Document Type: Conference Paper

References (70)

1. Becquerel H. Sur les radiations émises par les corps phosphorescents. Compt Rend Acad Sci Paris 1896; 122: 501.
2. Sklodowska Curie M. Recherches sur les substances radioactives. Thèse, Faculté des Sciences de Paris, June 12, 1903. Gauthier-Villars, Paris, 1904.
3. Sumiya H, Taki J, Miyauchi T, Tonami N, Tsuchiya H, Tomita K. Technetium-99m-MIBI scintigraphy in evaluation of bone and soft tissue lesions [abstract]. Eur J Nucl Med 1996; 23: 1104.
4. Tutus A, Nardali M, Gülmez I, Silov G, Kibar M, Karahacioglu E. Evaluation of primary lung cancer with Tc-99m-tetrofosmin in comparison to Tc-99m MIBI uptake [abstract]. Eur J Nucl Med 1996; 23: 1212.
5. Nakamura K, Sugawara I, Satake S, Kubo A, Takami H. Comparison of Tc-99m-MIBI and Tc-99m-tetrofosmin uptakes in anaplastic thyroid carcinoma [abstract]. Eur J Nucl Med 1996; 23: 1142.
6. Moretti JL, Duran Cordobes M, De Beco V, Boissier B, Kouyoumdjian JC, Chevillard S, Starzec A. MRP 190 and MDR Pgp 170 in human cancer cell lines: their influence on Tc-99m sestamibi uptake [abstract]. Eur J Nucl Med 1996; 23: 1093.
7. 99mTc-sestamibi scan for functional imaging of multidrug-resistant phenotype in untreated breast cancer patients [abstract]. Eur J Nucl Med 1996; 23: 1093.
8. Maurea S, Acampa W, Varrella P, Lastoria S, Mainolfi C, Wang H, Fimiani P, Panico MR, Abbate G, Salvatore M. Tc-99m MIBI imaging in the evaluation of patients with lymphomas: comparison with gallium-67 and F-18 FDG PET studies [abstract]. Eur J Nucl Med 1996; 23: 1207.
9. 11C]methionine predict survival? [abstract]. Eur J Nucl Med 1996; 23: 1107.
10. Scheidhauer K, Groth W, Pietrzyk U, Eschner W, Schaefer T, Dederichs B, Theissen P, Schicha H. Diagnosis of metastatic malignant melanoma: FDG PET in comparison to immunoscintigraphy [abstract]. Eur J Nucl Med 1996; 23: 1106.
11. Hustinx R, Paulus P, Benoit T, Jerusalem G, Jacquet N, Rigo P. Clinical value of wholebody FDG PET in the detection of liver metastases: preliminary results [abstract]. Eur J Nucl Med 1996; 23: 1110.
12. ™ in the management of patients (PTS) with carcinoma of the colon or rectum [abstract]. Eur J Nucl Med 1996; 23: 1109.
13. Breitz H, Ratliff B, Beaumier P, Kunz S, Fritzberg A. Intrapatient comparison of antibody NR-LU-10 pretargeted In-111 with Tc-99m Fab fragment for assessing targeted radiotherapy delivery [abstract]. Eur J Nucl Med 1996; 23: 1110.
14. Scopinaro F, Schillaci O, Ussov W, De Vincentis G, Nordling K, Danieli R, Ierardi M, Tavolaro R, Centi Colella A. Accuracy prone scintimammography (SM): a three-center study on 305 patients [abstract]. Eur J Nucl Med 1996; 23: 1091.
15. Tiling R, Sommer H, Moser R, Pechmann M, Meyer G, Pfluger T, Tatsch K, Hahn K. The role of sestamibi scintimammography and gadolinium enhanced MRI in the evaluation of microcalcifications detected by mammography [abstract]. Eur J Nucl Med 1996; 23: 1092.
16. Gómez-Barquín R, Quirce R, Blanco I, Uriarte I, Vega A, Banzo I, Carril JM. Tc-99m-MIBI scintimammography and mammographical probability of malignancy in the diagnosis of non-palpable breast lesions [abstract]. Eur J Nucl Med 1996; 23: 1092.
17. Kabasakal L, Hamidi M, Akman C, Ersavas G, Kanmaz B, Altug A, Erkman N, Nisli C, önsel ç. Tc-99m-MIBI scintimammography compared with mammography/ultrasonography combination and MRI in diagnosis of breast cancer: preliminary report [abstract]. Eur J Nucl Med 1996; 23: 1222.
18. Bohuslavizki KH, Brenner W, Bolling C, Lehmann-Willenbrock E, Brinkmann G, Wolf H, Sippel C, Clausen M, Henze E. Scintimammography using Tc-99m-tetrofosmin in pre-operative work-up of breast cancer [abstract]. Eur J Nucl Med 1996; 23: 1094.
19. Yagcioglu H, Ibis S, Naldöken S. Differentiation of malignant and benign breast mass using Tc99m-tetrofosmin: comparison with mammography, ultrasonography and biopsy [abstract]. Eur J Nucl Med 1996; 23: 1094.
20. Mansi L, Rambaldi PF, Cuccurullo V, Pecori B, Laprovitera A, Di Gregorio F, Procaccini E. Tc-99m tetrofosmin scintimammography: the complementary role in diagnosis of breast cancer [abstract]. Eur J Nucl Med 1996; 23: 1095.
21. Ivancevic V, Marnitz S, Winzer KJ, Aldinger HU, Reisinger I, Müller JM, Munz DL. Intraindividual comparison of Tc-99m sestamibi and Tc-99m tetrofosmin in prone and supine scintimammography [abstract]. Eur J Nucl Med 1996; 23: 1223.
22. Schillaci O, Scopinaro F, Danieli R, Tavolaro R, Picardi V, Cannas P, Ierardi M, Centi Colella A. Tc-99m tetrofosmin (TF) scintimammography (SMM): accuracy in patients with suspicion of breast (B) cancer (C) and comparison with Tc-99m MIBI [abstract]. Eur J Nucl Med 1996; 23: 1223.
23. 99mTc-sestamibi in the evaluation of lymphatic drainage in breast cancer [abstract]. Eur J Nucl Med 1996; 23: 1092.
24. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. Technetium-99m-sestamibi mammoscintigraphy of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
25. Bombardieri E, Crippa F, Agresti R, Greco M, Pascali C, Bogni A, Chiesa C, De Sanctis V, Decise D. Locoregional staging of primary breast cancer with FDG PET: preliminary results [abstract]. Eur J Nucl Med 1996; 23: 1093.
26. Palmedo H, Bender H, Schomburg A, Grünwald F, Indefrei D, Ebel T, Bangard M, Mallmann P, Overbeck B, Biersack HJ. Comparison of PET and scintimammography for the diagnosis of breast cancer [abstract]. Eur J Nucl Med 1996; 23: 1224.
27. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
28. 111In-pentetreotide (OCT) and Tc-99m-sestamibi (MIBI) [abstract]. Eur J Nucl Med 1996; 23: 1094.
29. Foekens JA, Portengen HM, van Putten WLJ, Trapman AMAC, Reubi JC, Alexieva-Figuch J, Klijn JGM. Prognostic value of receptors in insulin-like growth factor 1, somatostatin and epidermal growth factor in human breast cancer. Cancer Res 1989; 49: 7002-7009.
30. Béhé M, Heppeler A, Mäcke HR. New somatostatin analogs for SPECT and PET [abstract]. Eur J Nucl Med 1996; 23: 1144.
31. Taucher S, Kurtaran A, Leimer M, Angelberger P, Pangerl Th, Beck M, Gnant M, Jakesz R, Virgolini I. Vasoactive intestinal peptide (VIP) and somatostatin (SST) receptor scanning in primary breast cancer [abstract]. Eur J Nucl Med 1996; 23: 1094.
32. Rijks LJM, van Tienhoven G, Noorduyn LA, de Bruin K, Boer GJ, Janssen AGM, van Royen EA. Imaging of primary breast cancer with the estrogen receptor specific radioligand Z-[I-123[MIVE [abstract]. Eur J Nucl Med 1996; 23: 1096.
33. Pons F, Herranz R, Garcia A, Conill C, Verger E, Alcover A, Vidal-Sicart S, Lomeña F, Setoain J. Results of treatment of painful bone metastases with strontium-89 [abstract]. Eur J Nucl Med 1996; 23: 1117.
34. Limouris GS, Manetou M, Toubanakis N, Giannakopoulos V, Margaritaki M, Voliotopoulos V, Stavraka A, Vlahos L. Absorbed dose and analgetic duration after i.v. disodium pamidronate/Sr-89 chloride/Re-186 HEDP application in breast and prostate osseous metastases [abstract]. Eur J Nucl Med 1996; 23: 1116.
35. 153Sm-EDTMP locally produced in the treatment of metastatic bone pain [abstract]. Eur J Nucl Med 1996; 23: 1231.
36. 89SrCl [abstract]. Eur J Nucl Med 1996; 23: 1230.
37. 111In-DTPA-octreotide [abstract]. Eur J Nucl Med 1996; 23: 1118.
38. 1 [abstract]. Eur J Nucl Med 1996; 23: 1118.
39. Liu RS, Chu LS, Chang CP, Hsiau HY, Chou KL, Chang CW, Yeh SH. Assessment of the outcome of diabetic foot lesions by [F-18]fluoromisonidazole PET scan [abstract]. Eur J Nucl Med 1996; 23: 1035.
40. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, Claessens RAMJ, van der Meer JWM, Corstens FHM. The behaviour of radiolabeled human recombinant interleukin-1 in various mouse inflammation models [abstract]. Eur J Nucl Med 1996; 23: 1067.
41. Boerman OC, Oyen WJG, Storm G, van Bloois L, Koenders EB, van der Meer JWM, Corstens FHM. Tc-99m labeled PED-liposomes to image infection: effect of particle size and comparison with Tc-99m labeled leucocytes [abstract]. Eur J Nucl Med 1996; 23: 1068.
42. Oyen WJG, Boerman OC, Dams ETM, Storm G, von Bloois L, Koenders EB, Crommelin DJ, van der Meer JWM, Corstens FHM. Evaluation of experimental colitis with In-111 labeled liposomes, leucocytes, and IgG [abstract]. Eur J Nucl Med 1996; 23: 1062.
43. Weiland FL, Obranovich GT, Vande Streek PR, Carretta RF, Aliberti D. A new technetium-99m labeled peptide, P2870 in the evaluation of active thrombus formation: a prospective study in 32 patients [abstract]. Eur J Nucl Med 1996; 23: 1044.
44. 99mTc anti D dimer MoAb detects venous thrombi in man [abstract]. Eur J Nucl Med 1996; 23: 1064.
45. Rambaldi PF, Marino G, Valentino L, Masone F, Argenziano, Lama G, Mansi L. Urinary tract obstruction: the value of diuretic MAG3 scan follow-up [abstract]. Eur J Nucl Med 1996; 23: 1115.
46. Meyer G, Piepsz A, Fink FJ, Kolinska J, Lepej J, Sixt R, Hahn K. Tc-99m-MAG3-clearance "normal" values in children: a multicenter study [abstract]. Eur J Nucl Med 1996; 23: 1115.
47. Archambaud F, Bader-Meunier B, Baudet V, Ramadan A, Hignette C, Dommergues JP. DMSA renal scan in acute pyelonephritis in children (PNA): aged-related sensitivity [abstract]. Eur J Nucl Med 1996; 23: 1115.
48. Barthel H, Wiener M, Bettin S, Dannenherg C, Knapp WH. Age-dependence of cerebral perfusion - investigations of 4 to 15 year old children and adults with Tc-99m-ECD [abstract]. Eur J Nucl Med 1996; 23: 1082.
49. Ahonen A, Valkama M, Torniainen P, Vainionpää L, Koivisto M. Prospective study in high risk preterm neonates using TC-99m ECD brain SPET [abstract]. Eur J Nucl Med 1996; 23: 1114.
50. Bartenstein P, Kurz A, Hirsch C, Buch K, Willoch F, Minoshima S, Schwaiger M. Antagonistic effects of education and RCBF on cognitive performance in Alzheimer's disease [abstract]. Eur J Nucl Med 1996; 23: 1082.
51. Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T [123-I]-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease [abstract]. Eur J Nucl Med 1996; 23: 1080.
52. Tatsch K, Mozley PD, Schwarz J, Linke R, Pogarell O, Fieber RS, Hahn K, Hung HF. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter function assessed with [I-123] IPT and SPECT [abstract]. Eur J Nucl Med 1996; 23: 1080.
53. Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L. In vitro and in vivo characterization of nor-β-CIT: a new radioligand for visualization of the serotonin transporter in brain [abstract]. Eur J Nucl Med 1996; 23: 1090.
54. Åkerman KK, Kuikka JT, Bergström KA, Halldin C, Hiltunen J, Tiihonen J, Länsimies E, Farde L. Iodine-123 labelled nor-β-CIT as a potential tracer for the serotonin transporter imaging in the human brain [abstract]. Eur J Nucl Med 1996; 23: 1090.
55. 1A receptors in the postmortem human brain using [H-3]WAY-100635 and [C-11]WAY-100635 [abstract ]. Eur J Nucl Med 1996; 23: 1091.
56. 1A receptors in the monkey brain [abstract]. Eur J Nucl Med 1996; 23: 1091.
57. 2A receptors in the human brain [abstract]. Eur J Nucl Med 1996; 23: 1091.
58. Lindhardt TB, Gadsbøll N, Kelaek H, Saunamäki K, Kyst Madsen J, Jørgensen E, Hesse B. Continuous monitoring of left ventricular function during PTCA with a miniature nuclear detector [abstract]. Eur J Nucl Med 1996; 23: 1054.
59. Fikrle A, Lüscher D, Ritter EP, Fleisch M, Haldemann AR, Kinser JA, Lourens S. Comparison of the post-stress and rest left ventricular ejection fraction (EF) assessed by gated Tc-99m MIBI SPECT (GSPECT) [abstract]. Eur J Nucl Med 1996; 23: 1052.
60. Dogruca Z, Kabsakal L, Yapar AF, Vural VA, Nisli C, öngen Z, Erdogan N, önsel ç. The value of gated Tc-99m-MIBI SPECT in separation of inferior wall attenuation artifacts from myocardial infarction [abstract]. Eur J Nucl Med 1996; 23: 1053.
61. Kluge R, Seese A, Knapp WH. Non-uniform attenuation correction improves the quantitative evaluation of myocardial SPET studies [abstract]. Eur J Nucl Med 1996; 23: 1048.
62. Cuocolo A, Nicolai E, Squame F, Sullo P, Nappi A, Grivet Jojaja MR, Discepolo A, Spinelli L, Salvatore M. Prediction of spontaneous delayed recovery of contraction after myocardial infarction. Comparison between Tc-99m sestamibi tomography and dobutamine echocardiography [abstract]. Eur J Nucl Med 1996; 23: 1044.
63. Flotats A, Carrió I, Estorch M, Berná LI, Catafau AM, Ballester M. Nitrate administration to enhance detection of myocardial viability by Tc-99m-tetrofosmin SPECT [abstract]. Eur J Nucl Med 1996; 23: 1042.
64. Valkema R, Poldermans D, Reijs AEM, van Peski J, Rambaldi R, Fioretti PM, Krenning EP. Detection of myocardial viability by simultaneous acquisition of Tc-99m-tetrofosmin and 18-FDG using a 3-head SPECT camera [abstract]. Eur J Nucl Med 1996; 23: 1042.
65. Sinzinger H, Oguogho A, Rodrigues M, Peskar BA. Oxidized lipoprotein (a) for imaging atherosclerotic lesions? [abstract]. Eur J Nucl Med 1996; 23: 1044.
66. Severi S, Bettini R, Visona L, Lorenzi E, Camerani M. Functional dysinnervation of the left ventricle demonstred by 123I-MIBG scan in arrhythmogenic ventricular cardiomyopathy-dysplasia (AVC) [abstract]. Eur J Nucl Med 1996; 23: 1039.
67. Dresel S, Weiss M, Schnell O. Evidence for cardiac dysinnervation in patients with newly diagnosed idiopathic diabetes mellitus [abstract]. Eur J Nucl Med 1996; 23: 1039.
68. Le Guludec D, Dinanian S, Delahaye N, Merlet P, Mzabi H, Samuel D, Adams C, Slama M. Abnormal myocardial sympathetic innervation assessed by MIBG imaging in familial amyloidosis [abstract]. Eur J Nucl Med 1996; 23: 1038.
69. 123I-labelled IMT, β-CIT, MIBG and iodolisuride [abstract]. Eur J Nucl Med 1996; 23: 1134.
70. Lindahl D, Palmer J, Ohlsson M, Peterson C, Edenbrandt L. Automated interpretation of myocardial perfusion scintigrams using artificial neural networks [abstract]. Eur J Nucl Med 1996; 23: 1125.